Delivery Order SPE2DR25D1109-SPE2DR26FFF8A
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Durolane 60 mg/3 ml syringes with a ceiling value of $12,697.01. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. The order will be performed at the contractor's facility in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based injectable used primarily for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $15,826.78. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by June 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based intra-articular injection used for osteoarthritis treatment,...
- The Defense Logistics Agency awarded a $6,375.69 delivery order to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on May 6, 2025, with an ultimate completion date of May 7, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Durolane is a viscosupplement injection used for osteoarthritis treatment, reflecting the Defense Logistics Agency Medical...
- The Defense Logistics Agency awarded a delivery order valued at $9,965.97 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on September 2, 2025, with completion expected by September 3, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based intra-articular injection used for osteoarthritis treatment, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $4,781.85 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on May 5, 2025, with an ultimate completion date of May 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based injectable treatment commonly used for joint pain management,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,232.37 for Durolane 60 mg/3 ml syringes on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price, non-set-aside delivery order is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a single-use procurement of the injectable hyaluronic acid product, which is commonly used for osteoarthritis...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,105.80 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price, competitively awarded contract (non-set-aside) was executed on June 27, 2025, with an ultimate completion date of June 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based injectable used for osteoarthritis treatment, indicating...
- The Defense Logistics Agency awarded a $18,044.80 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price contract, with a completion date of September 11, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for DUROLANE 60MG/3ML, a hyaluronic acid-based joint injection used for osteoarthritis treatment. This firm fixed-price delivery order, valued at $9,790.21, was competitively awarded without set-aside designation and carries an ultimate completion date of October 22, 2025. The contract will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $8,453.04 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Durolane 60 mg/3 mL syringes. This firm fixed-price contract, with a completion date of July 29, 2025, represents a competitively awarded non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The products will be delivered to AmerisourceBergen's corporate office location in...